Latest Partnerships News

Hastings Technology Metals has responded to an ASX price query, denying any undisclosed information behind its recent share price and volume spike, citing recent joint venture and asset sale announcements as likely drivers.

NH3 Clean Energy updates investors on the WAH2 clean ammonia project, highlighting strong market potential, strategic partnerships, and robust project economics as it moves toward a Final Investment Decision.

PainChek Limited has achieved a landmark FDA De Novo classification for its PainChek Adult App, positioning it as the first regulated medical device for pain assessment in the US aged care sector and opening a $100 million annual market opportunity.

Anatara Lifesciences has completed the first tranche of its two-part share placement, issuing over 33 million ordinary shares to professional investors. This move marks a significant step in the company’s capital raising efforts amid ongoing product development.

KALiNA Power’s Canadian subsidiary has secured a substantial CAD 18 million from a one-off sale of allocated megawatts to a global data centre developer, marking a significant milestone in its Alberta power projects.

Vinyl Group’s subsidiary Funkified Entertainment is on track to meet its 2025 earn-out target, driven by major new contracts that reinforce the company’s vertical acquisition approach.

Pro Medicus Limited’s European arm, Visage Imaging, has landed a significant five-year, A$10 million contract to supply next-generation imaging technology to University Hospital Heidelberg and the German Cancer Research Institute, marking a strategic expansion in Europe.

First Au Limited’s initial drilling results at the Nimba Gold Project in Liberia reveal broad zones of gold mineralisation, validating geological models and hinting at significant resource potential.

Magellan Financial Group reported a modest rise in assets under management to A$40.2 billion as of 30 September 2025, reflecting shifts in retail and institutional investor activity.

Ovanti Limited has secured $8 million through a strategic share placement to accelerate its US Buy Now, Pay Later expansion, highlighted by a new three-year NASCAR sponsorship deal.

Immuron Limited has taken a significant step forward by submitting an Investigational New Drug application to the FDA for IMM-529, targeting Clostridioides difficile infection. The company aims to start Phase 2 trials in early 2026, addressing a critical unmet need in infectious disease treatment.

Airtasker has landed a £2.5 million media investment from Channel 4’s venture arm to accelerate growth in the UK, building on a strong marketplace performance and deepening a strategic media partnership.